首頁 > 市場調查報告書 > 醫療設備

導管

支架市場規模、佔有率和成長分析（按產品、材質、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1904288

支架市場規模、佔有率和成長分析（按產品、材質、最終用戶和地區分類）－2026-2033年產業預測

Stents Market Size, Share, and Growth Analysis, By Product (Vascular, Non-Vascular Stents), By Material (Metallic Stents, Non-Metallic Stents), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，支架市場規模將達到 96.1 億美元，到 2025 年將達到 99.2 億美元，到 2033 年將達到 128.7 億美元，在預測期（2026-2033 年）內，複合年成長率為 3.3%。

由於冠狀動脈疾病（主要死因之一）的發生率不斷上升，支架市場正經歷強勁成長。對先進醫療干預措施（尤其是藥物釋放型支架）的需求不斷成長，推動了市場擴張。技術創新不斷改進支架的設計和療效，而來自私人和政府機構的大量投資也為醫療研發注入了動力。支架的材質從塑膠到金屬不等，它們在維持血流方面發揮著至關重要的作用，能夠疏通動脈阻塞，預防動脈瘤等嚴重併發症。醫療技術的進步，加上心血管疾病發病率的不斷上升，使得支架成為現代醫療保健的關鍵組成部分，並為相關人員提供了持續的機遇，以有效滿足患者的迫切需求。

支架市場成長要素

心血管疾病發生率的不斷上升是支架市場成長的關鍵促進因素。隨著全球心血管疾病患者人數的增加，對支架的需求預計將會增加。慢性病盛行率的上升推動了醫療介入的需求，尤其是經皮冠狀動脈介入治療和周邊血管手術。由於心血管疾病在全球死亡人數中佔很大比例，因此對有效治療方法的需求更加迫切。因此，隨著越來越多的患者需要這些先進的手術，支架市場預計將大幅擴張，以滿足不斷成長的醫療需求。

支架市場的限制

由於嚴格的監管要求阻礙了支架市場的成長，該市場面臨巨大的挑戰。各監管機構制定了廣泛的指導方針，以確保支架的安全有效使用，要求在核准前對現有文獻和臨床前動物研究進行全面審查。由於冠狀動脈支架被歸類為高風險醫療設備，這個過程尤其耗費資源，需要大量的時間和資金投入。鑑於相關風險，支架的使用受到嚴格審查，這進一步加劇了市場動態。將這些器械歸類為中高風險產品增加了監管負擔，並最終抑制了市場需求。

支架市場趨勢

支架市場正經歷顯著成長，這主要得益於旨在改善患者預後的持續產品創新和改進。關鍵進展集中在降低支架梁厚度，以提高其在複雜血管解剖結構中的柔軟性和輸送性能，以及增加支架長度和直徑，以最佳化經皮冠狀動脈介入治療（PCI）。這個動態趨勢凸顯了業界致力於改善支架設計、應對手術挑戰並提升患者整體體驗的決心。隨著製造商加大研發投入以滿足醫療服務提供者和患者不斷變化的需求，預計未來幾年這一成長勢頭將推動市場強勁擴張。

血管
- 冠狀動脈支架
- 外周支架
- 髂動脈支架
- 股動脈支架
- 頸動脈支架
- 腎動脈支架
- 其他外周支架
- 神經血管支架
- 顱內支架
- 分流器
非血管支架
- 消化道支架
- 膽道
- 十二指腸
- 結腸
- 胰臟
- 食道支架
- 肺（氣道）支架
- 矽膠氣道
- 金屬氣道
- 泌尿系統支架
- 其他

全球支架市場規模（按材料和複合年成長率分類）（2026-2033 年）

金屬支架
非金屬支架

全球支架市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

醫院
專科診所
門診手術中心
其他

全球支架市場規模及複合年成長率（2026-2033）

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Boston Scientific
Medtronic
Abbott Laboratories
Terumo Corporation
Johnson & Johnson
B. Braun Melsungen AG
BIOTRONIK SE & Co. KG
Cook Medical
MicroPort Scientific Corporation
Sahajanand Medical Technologies
Alvimedica
Biosensors International
Lepu Medical Technology
Meril Life Sciences
Balton Sp. z oo
Translumina Therapeutics
Vascular Concepts
Relisys Medical Devices
Endocor GmbH
Hexacath

結論與建議

簡介目錄

Product Code: SQMIG35A2607

Stents Market size was valued at USD 9.61 Billion in 2024 and is poised to grow from USD 9.92 Billion in 2025 to USD 12.87 Billion by 2033, growing at a CAGR of 3.3% during the forecast period (2026-2033).

The stent market is experiencing robust growth due to rising rates of coronary artery disease, which is a leading cause of mortality. Increased demand for advanced medical interventions, particularly drug-eluting stents, is propelling market expansion. Technological innovations are enhancing stent design and efficacy, while substantial investments from both private and government entities are bolstering healthcare research and development. Stents, ranging from plastic to metal, play a critical role in maintaining blood flow by alleviating blockages in arteries and preventing serious complications such as aneurysms. The combination of medical advancements and the growing prevalence of cardiovascular issues underscores the vital importance of stents in contemporary healthcare, promising ongoing opportunities for market stakeholders to address urgent patient needs effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Stents Market Segments Analysis

Global Stents Market is segmented by product, material, end user and region. Based on product, the market is segmented into vascular and non-vascular stents. Based on material, the market is segmented into metallic stents and non-metallic stents. Based on end user, the market is segmented into hospitals, specialty clinics,ambulatory surgery centersand others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Stents Market

The increasing incidence of cardiovascular diseases is a significant catalyst for the growth of the stent market. As the number of individuals affected by cardiovascular conditions rises globally, the demand for stents is expected to escalate. A heightened prevalence of chronic illnesses leads to a greater need for medical interventions, particularly percutaneous coronary procedures and peripheral vascular surgeries. With cardiovascular diseases being responsible for a substantial percentage of global fatalities, the urgency for effective treatment options becomes more pronounced. Consequently, as more patients require these advanced procedures, the stent market is poised to experience significant expansion in response to this growing healthcare need.

Restraints in the Stents Market

The stents market faces significant challenges due to stringent regulatory requirements that impede its growth. Various regulatory bodies have implemented extensive guidelines to ensure the safe and effective use of stents, necessitating thorough reviews of existing literature and pre-clinical animal studies before approval. The process is notably resource-intensive, requiring considerable time and financial investment since coronary stents are categorized as high-risk devices. Due to the associated risks, strict oversight is maintained over stent usage, further complicating market dynamics. The classification of these devices as medium to high-risk entities adds to their regulatory burdens, ultimately dampening market demand.

Market Trends of the Stents Market

The stents market is experiencing significant growth driven by a wave of continuous product innovations and enhancements aimed at improving patient outcomes. Key advancements focus on reducing stent strut thickness to enhance flexibility and deliverability in complex vascular anatomies, alongside the introduction of longer lengths and smaller diameters to optimize percutaneous coronary interventions (PCI). This dynamic trend underscores the industry's commitment to refining stent designs, addressing procedural challenges, and elevating the overall patient experience. As manufacturers invest in research and development to meet the evolving needs of healthcare providers and patients, this trajectory is expected to facilitate robust market expansion in the years to come.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Trade Analysis

Global Stents Market Size by Product & CAGR (2026-2033)

Market Overview
Vascular
- Coronary Stents
- Peripheral Stents
- Iliac Artery Stents
- Femoral Artery Stents
- Carotid Artery Stents
- Renal Artery Stents
- Other Peripheral Stents
- Neurovascular Stents
- Intracranial Stents
- Flow Diverters
Non-Vascular Stents
- Gastrointestinal Stents
- Biliary
- Duodenal
- Colonic
- Pancreatic
- Esophageal Stents
- Pulmonary (Airway) Stents
- Silicone Airway
- Metallic Airway
- Urological Stents
- Others

Global Stents Market Size by Material & CAGR (2026-2033)

Market Overview
Metallic Stents
Non-Metallic Stents

Global Stents Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Specialty Clinics
Ambulatory Surgery Centers
Others

Global Stents Market Size & CAGR (2026-2033)

North America (Product, Material, End User)
- US
- Canada
Europe (Product, Material, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Material, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Material, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Material, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Boston Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOTRONIK SE & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sahajanand Medical Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alvimedica
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosensors International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meril Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Balton Sp. z o.o.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Translumina Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vascular Concepts
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Relisys Medical Devices
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endocor GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hexacath
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments